Novo CEO pressed by Senate to cut prices of obesity, diabetes medications CEO Lars Fruergaard Jørgensen informed lawmakers the corporate would contemplate new talks with insurers with regards to the listing selling prices of Wegovy and copyright should they pledge to keep the medicines on their formularies. Will not overlook https://buschpeachcalories71615.life3dblog.com/29889262/the-smart-trick-of-healthcare-news-that-nobody-is-discussing